Use the search to find what you are looking for

CANCER OF UNKNOWN PRIMARY FOUNDATION

Blog

12 Apr 2017

NICE have decided not to review the CUP Guideline having been advised of advances in immunohistochemistry markers and molecular profiling since the guideline was developed. The decision is shown here and, more interestingly, the evidence on which the decision was made is shown here. The recommendations from the review question are: Immunohistochemistry 1.2.2.7 Use a panel of antibodies comprising cytokeratin 7 (CK7),Read more